Objective: This study determined differences in outcomes among respondents with and without a depression diagnosis and across symptom severity in respondents with diagnosed depression.
...
Background: SAGE-217 is a novel, positive allosteric modulator of GABA(A) receptors under development in Major Depressive Disorder (MDD). This analysis quantified the number needed to tre...